Vical Updates Herpes Simplex Vaccine Development at ASGCT Conference 
MarketWatch (press release)
Both prophylactic vaccines significantly reduced viral replication at the primary genital infection site. -- Both prophylactic vaccines significantly reduced detectable HSV-2 infection at the dorsal root ganglia latent site.

and more » 

Vical Updates Herpes Simplex Vaccine Development at ASGCT Conference 
NASDAQ
Both prophylactic vaccines significantly reduced viral replication at the primary genital infection site. Both prophylactic vaccines significantly reduced detectable HSV-2 infection at the dorsal root ganglia latent site. The therapeutic pDNA vaccine ...

and more » 

From Circumcision To Molestation, How the Orthodox Place Children At Risk 
Daily Beast
At least two babies have died in the past decade, and several more have faced severe health consequences, because they were infected with herpes simplex during a rare and controversial part of the ritual used by a very few ultra-Orthodox mohels in ...

and more » 

Increasing Number of HSV Cases to Drive Global Herpes Simplex Virus Treatment ... 
San Francisco Chronicle (press release)
The global market for herpes simplex virus treatment is forecast to reach $4.9 billion by the year 2017. Principal growth drivers include increasing number of people affected by herpes simplex virus (HSV) infection, need for innovative therapies, ...

and more » 

GenturaDx to Host Workshop on Herpes Simplex Virus at Clinical Virology ... 
San Francisco Chronicle (press release)
Genital HSV is the leading sexually transmitted disease in the United States with over 50 million (1) individuals infected and over 1.6 million (2) new infections per year. Reducing further transmissions by raising awareness through accurate testing is ...

and more » 

FDA Approves Foscarnet for HIV-Related CMV Retinitis, Herpes 
Medscape
Foscarnet sodium is now indicated for the treatment of CMV retinitis in patients with HIV and acyclovir-resistant mucocutaneous herpes simplex virus infections in immune-compromised patients in the United States, in addition to its availability in ...

and more » 

Genocea Highlights Key Progress in the Development of its First Vaccine ... 
MarketWatch (press release)
CAMBRIDGE, Mass., May 04, 2012 (BUSINESS WIRE) -- Genocea Biosciences announced today the results of two studies that showcase the company's efforts to develop the first-ever therapeutic vaccine for HSV-2 (herpes simplex virus type 2).

and more » 

Vical's CEO Presents at Bank of America Merrill Lynch Health Care Conference ... 
Seeking Alpha
And then we have an exciting preclinical program for Herpes Simplex 2, where nothing is really going on, but one out of three people in the US are HSV-2 positive. We have number of partnerships with major pharma companies.

and more » 

Researchers Present Data Highlighting Potential of Peregrine's PS-Targeting ... 
SYS-CON Media (press release)
Data from this study further broadens the potential of our PS-targeting platform in the area of viral disease," said Cyril Empig, Ph.D., associate director, infectious diseases, at Peregrine. "With herpes simplex keratitis affecting approximately ...

and more » 

HEALTH CARE AND HERPES 
The Cypress Times
In HSV-2, the infected person may have sores around the genitals or rectum. Although HSV-2 sores may occur in other locations, these sores usually are found below the waist. Although genital herpes used to almost always be caused by HSV-2 infection, ...